The MarketWatch News Department was not involved in the creation of this content. National pre-settlement funding provider continues strategic focus on late-stage, mid-stage, and emerging ...
National pre-settlement funding provider continues strategic focus on late-stage, mid-stage, and emerging pharmaceutical and medical device litigation JERSEY CITY, N.J., March 5, 2026 /PRNewswire/ -- ...
Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive valid, exclusive mass tort cases. Our program is built on a ‘Medical-First’ ...
FMC's rimisoxafen was classified as a dual mode of action herbicide by the Herbicide Resistance Action Committee. The agricultural sciences company said the decision makes rimisoxafen the first ...
A collaborative research team has uncovered a previously unknown mechanism of action of yaku'amide B, a structurally complex peptidic natural product derived from deep-sea sponge found in the waters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results